Teduglutide 0.05 dose

DRUG2 trials

Sponsors

Shire, International Centre for Diarrhoeal Disease Research, Bangladesh

Conditions

Crohn's DiseaseEnvironmental Enteric Dysfunction

Phase 2

Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease

CompletedNCT00072839

ShireCrohn's Disease

Start: 2003-11-12End: 2005-07-28Updated: 2021-05-25

Glucagon-like Peptide 2 (GLP-2) in Undernourished Women Improving From Histology-Confirmed Environmental Enteric Dysfunction (EED)

Not yet recruitingNCT07537686

International Centre for Diarrhoeal Disease Research, BangladeshEnvironmental Enteric Dysfunction

Start: 2026-07-01End: 2027-12-30Target: 55Updated: 2026-04-17